newsfilter
← Latest News
Business Wire·

Aptinyx Appoints Gilmore O'Neill, M.B., M.M.Sc., to Board of Directors

Aptinyx Inc. (NASDAQ:APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of nervous system disorders, today announced the appointment of Gilmore O'Neill, M.B., M.M.Sc., to the company's board of direct